Rivia · $15M · Series A

Zurich-based Rivia, a data engine for clinical trial intelligence, announced a $15 million Series A round led by Earlybird. The company aims to fix the broken data infrastructure behind clinical trials. Existing investors Speedinvest and Amino also participated.

AI-generated: summaries written by AI from the linked sources. How we use AI